The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Effect of Erythropoietin and Transfusion Threshold on Neurological Recovery After Traumatic Brain Injury: A Randomized Clinical Trial
Open accessAbstract
IMPORTANCE: There is limited information about the effect of erythropoietin or a high hemoglobin transfusion threshold after a traumatic brain injury. OBJECTIVE: To compare the effects of erythropoietin and 2 hemoglobin transfusion thresholds (7 and 10 g/dL) on neurological recovery after traumatic brain injury. DESIGN, SETTING, AND PARTICIPANTS: Randomized clinical trial of 200 patients (erythropoietin, n = 102; placebo, n = 98) with closed head injury who were unable to follow commands and were enrolled within 6 hours of injury at neurosurgical intensive care units in 2 US level I trauma centers between May 2006 and August 2012. The study used a factorial design to test whether erythropoietin would fail to improve favorable outcomes by 20% and whether a hemoglobin transfusion threshold of greater than 10 g/dL would increase favorable outcomes without increasing complications. Erythropoietin or placebo was initially dosed daily for 3 days and then weekly for 2 more weeks (n = 74) and then the 24- and 48-hour doses were stopped for the remainder of the patients (n = 126). There were 99 patients assigned to a hemoglobin transfusion threshold of 7 g/dL and 101 patients assigned to 10 g/dL. INTERVENTIONS: Intravenous erythropoietin (500 IU/kg per dose) or saline. Transfusion threshold maintained with packed red blood cells. MAIN OUTCOMES AND MEASURES: Glasgow Outcome Scale score dichotomized as favorable (good recovery and moderate disability) or unfavorable (severe disability, vegetative, or dead) at 6 months postinjury. RESULTS: There was no interaction between erythropoietin and hemoglobin transfusion threshold. Compared with placebo (favorable outcome rate: 34/89 [38.2%; 95% CI, 28.1% to 49.1%]), both erythropoietin groups were futile (first dosing regimen: 17/35 [48.6%; 95% CI, 31.4% to 66.0%], P = .13; second dosing regimen: 17/57 [29.8%; 95% CI, 18.4% to 43.4%], P < .001). Favorable outcome rates were 37/87 (42.5%) for the hemoglobin transfusion threshold of 7 g/dL and 31/94 (33.0%) for 10 g/dL (95% CI for the difference, -0.06 to 0.25, P = .28). There was a higher incidence of thromboembolic events for the transfusion threshold of 10 g/dL (22/101 [21.8%] vs 8/99 [8.1%] for the threshold of 7 g/dL, odds ratio, 0.32 [95% CI, 0.12 to 0.79], P = .009). CONCLUSIONS AND RELEVANCE: In patients with closed head injury, neither the administration of erythropoietin nor maintaining hemoglobin concentration of greater than 10 g/dL resulted in improved neurological outcome at 6 months. The transfusion threshold of 10 g/dL was associated with a higher incidence of adverse events. These findings do not support either approach in this setting. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00313716.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multiple Imputation for Nonresponse in Surveys
Rubin, D. B. (1987) · Wiley Series in Probability and Statistics · doi:10.1002/9780470316696 · Cited by 20,701
Baker, S. P., O’Neill, B., Haddon, W. F., & Long, W. B. (1974) · PubMed · Cited by 7,946
Bernard, G. R., Artigas, A., Brigham, K. L., Carlet, J., Falke, K., Hudson, L., Lamy, M., Legall, J. R., Morris, A., & Spragg, R. (1994) · American journal of respiratory and critical care medicine · doi:10.1164/ajrccm.149.3.7509706 · Cited by 6,746
A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care
Hébert, P. C., Wells, G., Blajchman, M. A., Marshall, J., Martin, C., Pagliarello, G., Tweeddale, M., Schweitzer, I., & Yetisir, E. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400601 · Cited by 5,187
WILSON, J. T. L., PETTIGREW, L. E. L., & TEASDALE, G. M. (1998) · Journal of Neurotrauma · doi:10.1089/neu.1998.15.573 · Cited by 2,386 · cited 1×
“Placebo (n = 98) 1b (n = 38) 2b (n = 64) 7 (n = 99) 10 (n = 101) Age, median (IQR), y 32 (23-48) 29 (23-47) 30 (22-44) 28 (21-48) 31 (24-45)”
A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care
(1999) · New England Journal of Medicine · doi:10.1056/nejm199904013401322 · Cited by 2,037
Steyerberg, E. W., Mushkudiani, N., Perel, P., Butcher, I., Lu, J., McHugh, G. S., Murray, G. D., Marmarou, A., Roberts, I., Habbema, J. D. F., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050165 · Cited by 1,431
Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
Brines, M. L., Ghezzi, P., Keenan, S., Agnello, D., de Lanerolle, N. C., Cerami, C., Itri, L. M., & Cerami, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.19.10526 · Cited by 1,402
Transfusion Strategies for Patients in Pediatric Intensive Care Units
Lacroix, J., Hébert, P. C., Hutchison, J. S., Hume, H. A., Tucci, M., Ducruet, T., Gauvin, F., Collet, J.-P., Toledano, B. J., Robillard, P., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066240 · Cited by 1,085
Transfusion Requirements After Cardiac Surgery: The TRACS Randomized Controlled Trial
Hajjar, L. A., Vincent, J.-L., Galas, F. R. B. G., Nakamura, R. E., Silva, C. M. P., Santos, M. H., Fukushima, J., Filho, R. K., Sierra, D. B., Lopes, N. H., et al. (2010) · JAMA · doi:10.1001/jama.2010.1446 · Cited by 1,054
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
Sirén, A.-L., Fratelli, M., Brines, M., Goemans, C., Casagrande, S., Lewczuk, P., Keenan, S., Gleiter, C., Pasquali, C., Capobianco, A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051606598 · Cited by 1,019
Maas, A. I. R., Hukkelhoven, C. W. P. M., Marshall, L. F., & Steyerberg, E. W. (2005) · Neurosurgery · doi:10.1227/01.neu.0000186013.63046.6b · Cited by 939
The diagnosis of head injury requires a classification based on computed axial tomography.
Lf, M., Sb, M., Klauber, M. R., van Berkum-Clark, M., Eisenberg, H. M., Jane, J. A., Luerssen, T. G., Marmarou, A., & Ma, F. (1992) · PubMed · Cited by 780
Bernard, G. R., Artigas, A., Brigham, K. L., Carlet, J., Falke, K., Hudson, L., Lamy, M., LeGall, J. R., Morris, A., Spragg, R., et al. (1994) · Intensive Care Medicine · doi:10.1007/bf01704707 · Cited by 696
Recombinant Human Erythropoietin in the Treatment of Acute Ischemic Stroke
Ehrenreich, H., Weissenborn, K., Prange, H., Schneider, D., Weimar, C., Wartenberg, K., Schellinger, P. D., Bohn, M., Becker, H., Wegrzyn, M., et al. (2009) · Stroke · doi:10.1161/strokeaha.109.564872 · Cited by 605
Villa, P., Bigini, P., Mennini, T., Agnello, D., Laragione, T., Cagnotto, A., Viviani, B., Marinovich, M., Cerami, A., Coleman, T. R., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021067 · Cited by 527
McIntyre, L. A., Fergusson, D. A., Hutchison, J. S., Pagliarello, G., Marshall, J. C., Yetisir, E., Hare, G. M. T., & Hébert, P. C. (2006) · Neurocritical Care · doi:10.1385/ncc:5:1:4 · Cited by 238
Zygun, D. A., Nortje, J., Hutchinson, P. J., Timofeev, I., Menon, D. K., & Gupta, A. K. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e318194ad22 · Cited by 199
Murray, G. D., Barer, D. H., Choi, S. C., Fernandes, H. M., GREGSON, B. A., Lees, K. R., Maas, A. I. R., Marmarou, A., Mendelow, A. D., Steyerberg, E. W., et al. (2005) · Journal of Neurotrauma · doi:10.1089/neu.2005.22.511 · Cited by 167
Xiong, Y., Mahmood, A., Meng, Y., Zhang, Y., Qu, C., Schallert, T. J., & Chopp, M. (2009) · Journal of neurosurgery · doi:10.3171/2009.9.jns09844 · Cited by 115
Cherian, L., Goodman, J. C., & Robertson, C. S. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.119628 · Cited by 106
Self-citationTransfusions and long-term functional outcomes in traumatic brain injury: Clinical article
Warner, M. A., O’Keeffe, T., Bhavsar, P., Shringer, R., Moore, C. B., Harper, C. R., Madden, C. J., Sarode, R., Gentilello, L. M., & Diaz-Arrastia, R. R. (2010) · Journal of neurosurgery · doi:10.3171/2009.12.jns091337 · Cited by 83
Improved Survival of Critically Ill Trauma Patients Treated With Recombinant Human Erythropoietin
Napolitano, L. M., Fabian, T. C., Kelly, K. M., Bailey, J. A., Block, E. F. J., Langholff, W. K., Enny, C., & Corwin, H. L. (2008) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0b013e31817f2c6e · Cited by 78
Optimizing the ongoing search for new treatments for Parkinson disease: Using futility designs
Tilley, B. C., Palesch, Y. Y., Kieburtz, K. D., Ravina, B. M., Huang, P., Elm, J. J., Shannon, K. M., Wooten, G. F., Tanner, C. M., & Goetz, G. C. (2006) · Neurology · doi:10.1212/01.wnl.0000201251.33253.fb · Cited by 76
Self-citationElterman, J. B., Brasel, K. J., Brown, S. P., Bulger, E. M., Christenson, J. M., Kerby, J. D., Kannas, D. A., Lin, S., Minei, J. P., Rizoli, S., et al. (2013) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0b013e318298492e · Cited by 71
Meng, Y., Xiong, Y., Mahmood, A., Zhang, Y., Qu, C., & Chopp, M. (2011) · Journal of neurosurgery · doi:10.3171/2011.3.jns101721 · Cited by 67
Transfusion practices for acute traumatic brain injury: a survey of physicians at US trauma centers
Sena, M. J., Rivers, R. M., Muizelaar, J. P., Battistella, F. D., & Utter, G. H. (2008) · Intensive Care Medicine · doi:10.1007/s00134-008-1289-z · Cited by 61
The effect of blood transfusion on brain oxygenation in children with severe traumatic brain injury*
Figaji, A., Zwane, E. N., Kogels, M., Fieggen, G. A. G., Argent, A. C., Roux, P. D. L., & Peter, J. C. (2009) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0b013e3181b80a8e · Cited by 57
Talving, P., Lustenberger, T., Inaba, K., Lam, L., Mohseni, S., Chan, L., & Demetriades, D. (2012) · Archives of Surgery · doi:10.1001/archsurg.2011.1838 · Cited by 28
Tibshirani (1997) · doi:10.1002/(sici)1097-0258(19970228)16:4<385::aid-sim380>3.0.co;2-3
Cited by
Rossaint, R., Bouillon, B., Cerny, V., Coats, T. J., Duranteau, J., Fernández-Mondéjar, E., Filipescu, D., Hunt, B. J., Komadina, R., Nardi, G., et al. (2016) · Critical Care · doi:10.1186/s13054-016-1265-x · Cited by 1,484
Spahn, D. R., Bouillon, B., Cerny, V., Duranteau, J., Filipescu, D., Hunt, B. J., Komadina, R., Maegele, M., Nardi, G., Riddez, L., et al. (2019) · Critical Care · doi:10.1186/s13054-019-2347-3 · Cited by 1,269
Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion
Carson, J. L., Stanworth, S. J., Roubinian, N., Fergusson, D. A., Triulzi, D., Doree, C., & Hebert, P. C. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002042.pub4 · Cited by 1,250
The far-reaching scope of neuroinflammation after traumatic brain injury
Simon, D. W., McGeachy, M. J., Bayır, H., Clark, R. S. B., Loane, D. J., & Kochanek, P. M. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.13 · Cited by 1,190
Rossaint, R., Afshari, A., Bouillon, B., Cerny, V., Cimpoesu, D., Curry, N., Duranteau, J., Filipescu, D., Grottke, O., Grønlykke, L., et al. (2023) · Critical Care · doi:10.1186/s13054-023-04327-7 · Cited by 776
Metadata
- Authors
- Robertson, C. S., Hannay, H. J., Yamal, J.-M., Gopinath, S., Goodman, J. C., Tilley, B. C., Baldwin, A., Rivera Lara, L., Saucedo-Crespo, H., Ahmed, O., Sadasivan, S., Ponce, L., Cruz-Navarro, J., Shahin, H., Aisiku, I. P., Doshi, P., Valadka, A., Neipert, L., Waguspack, J. M., Rubin, M. L., Benoit, J. S., & Swank, P.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2014-07-02
- Volume
- 312
- Issue
- 1
- Pages
- 36
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2159026586
- Cited by
- 525
- References
- 30
- FWCI
- 35.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.